Liver Diseases in South Korea: A Pulse Check of the Public’s Knowledge, Awareness, and Behaviors
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: National surveys in Korea have spotlighted suboptimal levels of awareness among the public towards liver-related health and diseases, leading to progressive reform of national policies and education efforts. This study aimed to assess the status of the Korean public’s knowledge towards liver-related diseases. Materials and Methods: A self-reported, cross-sectional, web-based questionnaire study was conducted between February–March 2020 among 1000 Korean adults. Questionnaire items assessed the knowledge, awareness, and behaviors towards liver-related health and diseases. Results: About half (50.9%–52.1%) knew untreated/chronic viral hepatitis could lead to liver failure and/or cancer. Misconceptions pertaining to viral hepatitis transmission risks exist with only 26.3% knowing viral hepatitis B cannot be transmitted by dining with an infected individual. About one-fifth (22.2%) were aware of an available cure for viral hepatitis C. Less than half were aware of the risk factors associated with nonalcoholic steatohepatitis (NASH), despite 72.4% and 49.5% having heard of fatty liver disease and NASH, respectively. More than one-third were unlikely to seek medical consultation even if exposed to viral hepatitis risk factors or upon diagnosis with a liver condition. Reasons for this low urgency included costs-related concerns, perceptions of being healthy, and the viewpoint that the condition is not life-threatening. Conclusion: The public’s knowledge towards liver-related diseases in Korea was found to be lacking, which could account for a lower sense of urgency towards screening and treatment. More efforts are needed to address misperceptions and dispel stigma in an effort to encourage pro-health seeking behaviors.
Abstract
Purpose: National surveys in Korea have spotlighted suboptimal levels of awareness among the public towards liver-related health and diseases, leading to progressive reform of national policies and education efforts. This study aimed to assess the status of the Korean public’s knowledge towards liver-related diseases. Materials and Methods: A self-reported, cross-sectional, web-based questionnaire study was conducted between February–March 2020 among 1000 Korean adults. Questionnaire items assessed the knowledge, awareness, and behaviors towards liver-related health and diseases. Results: About half (50.9%–52.1%) knew untreated/chronic viral hepatitis could lead to liver failure and/or cancer. Misconceptions pertaining to viral hepatitis transmission risks exist with only 26.3% knowing viral hepatitis B cannot be transmitted by dining with an infected individual. About one-fifth (22.2%) were aware of an available cure for viral hepatitis C. Less than half were aware of the risk factors associated with nonalcoholic steatohepatitis (NASH), despite 72.4% and 49.5% having heard of fatty liver disease and NASH, respectively. More than one-third were unlikely to seek medical consultation even if exposed to viral hepatitis risk factors or upon diagnosis with a liver condition. Reasons for this low urgency included costs-related concerns, perceptions of being healthy, and the viewpoint that the condition is not life-threatening. Conclusion: The public’s knowledge towards liver-related diseases in Korea was found to be lacking, which could account for a lower sense of urgency towards screening and treatment. More efforts are needed to address misperceptions and dispel stigma in an effort to encourage pro-health seeking behaviors.
참고문헌 (36)
- Lin L, "The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017at the global, regional, national, age, and sex level results from the global burden of disease study 2017", Liver Cancer, 9, pp.563~582 (2020)
- Sepanlou SG, "The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017 : a systematic analysis for the global burden of disease study 2017", Lancet Gastroenterol Hepatol, 5, pp.245~266 (2020)
- "Global health sector strategy on viral hepatitis, 2016–2021"[URL]
- Joon Yeul Nam, "Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study", Gut and Liver, 14(2), pp.207~217 (2020), 거트앤리버 소화기연관학회협의회
- 김보현, "Epidemiology of liver cancer in South Korea", Clinical and Molecular Hepatology, 24(1), pp.1~9 (2018), 대한간학회
- Pak S, "Viral hepatitis in South Korea", Euroasian J Hepatogastroenterol, 7, pp.163~165 (2017)
- Seung Ha Park, "Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017", Clinical and Molecular Hepatology, 26(2), pp.209~215 (2020), 대한간학회[DOI]
- 임선영, "The epidemiology of hepatitis B virus infection in Korea", The Korean Journal of Internal Medicine, 34(5), pp.945~953 (2019), 대한내과학회[DOI]
- Kim T, "Factors associated with hepatitis C antibody positivity in Korean adults: a cross-sectional study based on 2013-2018 Korea National Health and Nutrition Examination Survey", Healthcare (Basel), 9, pp.1366~ (2021)
- Polaris Observatory HCV Collaborators, "Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study", Lancet Gastroenterol Hepatol, 2, pp.161~176 (2017)
- Polaris Observatory Collaborators, "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016 : a modelling study", Lancet Gastroenterol Hepatol, 3, pp.383~403 (2018)
- "The 17th liver day celebration ceremony"[URL]
- Korean Association for the Study of the Liver, "White paper on liver disease in Koreans", pp.44~ (2013), Korean Association for the Study of the Liver
- Kim BK, "Current status of and strategies for hepatitis C control in South Korea", Clin Mol Hepatol, 23, pp.212~218 (2017)
- Cho EJ, "Current status and strategies for hepatitis B control in Korea", Clin Mol Hepatol, 23, pp.205~211 (2017)
- Im HJ, "Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea", Clin Res Hepatol Gastroenterol, 45, pp.101526~ (2021)
- Park J, "NASH", liver fibrosis prevalence and incidence of nonliver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidities : lessons from South Korea, 2021, pp.39, 634~645
- Lee MH, "Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases : a large-scale Asian study", J Viral Hepat, 29, pp.156~170 (2022)
- Choi Gwang Hyeon, "A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea", Gut and Liver, 14(6), pp.808~816 (2020), 거트앤리버 소화기연관학회협의회[DOI]
- Lee H, "Correlates of hepatitis B virus-related stigmatization experienced by asians : a scoping review of literature", Asia Pac J Oncol Nurs, 3, pp.324~334 (2016)
- Marinho RT, "Hepatitis C, stigma and cure", World J Gastroenterol, 19, pp.6703~6709 (2013)
- Smith-Palmer J, "Impact of stigma on people living with chronic hepatitis B", Patient Relat Outcome Meas, 11, pp.95~107 (2020)
- Zacks S, "Social stigmatization and hepatitis C virus infection", J Clin Gastroenterol, 40, pp.220~224 (2006)
- Coffin PO, "Cost-effectiveness and population outcomes of general population screening for hepatitis C", Clin Infect Dis, 54, pp.1259~1271 (2012)
- Kim J, "Cost-effectiveness of scaling up of hepatitis C screening and treatment : a modelling study in South Korea", BMJ Glob Health, 4, pp.e001441~ (2019)
- Cramp ME, "Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality", BMC Gastroenterol, 14, pp.137~ (2014)
- Kim DY, "Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea", Curr Med Res Opin, 36, pp.993~1002 (2020)
- Estes C, "Modelling NAFLD disease burden in four Asian regions-2019-2030", Aliment Pharmacol Ther, 51, pp.801~811 (2020)
- Seto WK, "Nonalcoholic fatty liver disease in Asia : emerging perspectives", J Gastroenterol, 52, pp.164~174 (2017)
- Ngu JH, "Managing non-alcoholic fatty liver disease", Singapore Med J, 57, pp.368~371 (2016)
- Abd El-Kader SM, "Non-alcoholic fatty liver disease : the diagnosis and management", World J Hepatol, 7, pp.846~858 (2015)
- Shin A, "Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea", Cancer Epidemiol Biomarkers Prev, 18, pp.1894~1898 (2009)
- [URL]
- Hirnschall G, "There’s a reason viral hepatitis has been dubbed the ‘silent killer" (2015), World Health Organization
- Asrani SK, "Burden of liver diseases in the world", J Hepatol, 70, pp.151~171 (2019)
- "2020 Population and housing census (registerbased census)"[URL]